Pfizer’s maternal respiratory syncytial virus vaccine is ready to submit for FDA approval by the end of the year, CNN reported Nov. 1.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News